Chemed Corporation (NYSE:CHE) Receives Average Rating of “Hold” from Brokerages

Shares of Chemed Corporation (NYSE:CHE) have received an average rating of “Hold” from the six analysts that are presently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is $501.50.

Several equities research analysts have commented on the company. Royal Bank Of Canada upped their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Oppenheimer dropped their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.33% of the stock is owned by insiders.

Institutional Investors Weigh In On Chemed

Several institutional investors and hedge funds have recently modified their holdings of the stock. Commonwealth Equity Services LLC boosted its position in shares of Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after buying an additional 22 shares during the period. WCM Investment Management LLC boosted its position in shares of Chemed by 3.8% in the third quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock worth $299,000 after buying an additional 24 shares during the period. Eukles Asset Management boosted its position in shares of Chemed by 0.4% in the third quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock worth $2,700,000 after buying an additional 24 shares during the period. Cim LLC boosted its position in shares of Chemed by 1.1% in the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after buying an additional 24 shares during the period. Finally, Smartleaf Asset Management LLC boosted its position in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of NYSE:CHE opened at $440.38 on Friday. The firm has a market capitalization of $5.84 billion, a PE ratio of 24.00, a P/E/G ratio of 1.65 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The business has a 50-day moving average of $398.72 and a two-hundred day moving average of $424.87. Chemed has a 12 month low of $365.20 and a 12 month high of $581.20.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the firm posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, research analysts forecast that Chemed will post 22.3 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be given a $0.60 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s dividend payout ratio is presently 13.08%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.